AARDVARK THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
AARDVARK THERAPEUTICS, INC. (AARD) reported Increase Decrease In Operating Lease Liability of -$210.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-11
- AARDVARK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$105.00K.
- AARDVARK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$105.00K.
- AARDVARK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$104.00K.
- AARDVARK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$100.00K.
- AARDVARK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$338.00K.
- AARDVARK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$198.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$210.00K 10-Q · filed 2026-08-11 | -$314.00K derived: sum of 3 quarters · filed 2026-08-11 | -$414.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$105.00K 10-Q · filed 2026-05-07 | -$209.00K derived: sum of 2 quarters · filed 2026-05-07 | -$309.00K derived: sum of 3 quarters · filed 2026-05-07 | -$390.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$204.00K derived: sum of 2 quarters · filed 2026-03-23 | -$285.00K derived: sum of 3 quarters · filed 2026-08-11 | -$338.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$181.00K derived: sum of 2 quarters · filed 2026-08-11 | -$234.00K 10-Q · filed 2025-11-13 | -$323.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$134.00K 10-Q · filed 2026-08-11 | -$223.00K derived: sum of 3 quarters · filed 2026-08-11 | -$278.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$53.00K 10-Q · filed 2026-05-07 | -$142.00K derived: sum of 2 quarters · filed 2026-05-07 | -$197.00K derived: sum of 3 quarters · filed 2026-05-07 | -$224.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$144.00K derived: sum of 2 quarters · filed 2026-03-23 | -$171.00K derived: sum of 3 quarters · filed 2026-03-23 | -$198.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$82.00K derived: sum of 2 quarters · filed 2025-11-13 | -$109.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$54.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$27.00K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |